Pharvaris has adjusted its guidance for topline results from its [...]

VIVES Partners, managing company of VIVES Funds, has joined a [...]

New analysis reveals billions risked on overly complex trials that [...]

RNA therapeutics biotech Ochre Bio has appointed its founder and [...]

New alliance targets early 2026 for first-in-human trial of non-opioid [...]

Poland-based CDMO Mabion has completed the first GMP-compliant batch of [...]

CluePoints releases full speaker lineup for free virtual event focused [...]

PhaseV has secured $50 million in Series A funding to [...]